RhumbLine Advisers’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09K | Sell |
|
|||||
|
2025
Q1 | $24.5K | Sell |
|
|||||
|
2024
Q4 | $138K | Buy |
|
|||||
|
2024
Q3 | $336K | Sell |
|
|||||
|
2024
Q2 | $156K | Buy |
|
|||||
|
2024
Q1 | $194K | Buy |
|
|||||
|
2023
Q4 | $160K | Buy |
|
|||||
|
2023
Q3 | $156K | Sell |
|
|||||
|
2023
Q2 | $192K | Buy |
|
|||||
|
2023
Q1 | $205K | Buy |
|
|||||
|
2022
Q4 | $251K | Buy |
|
|||||
|
2022
Q3 | $324K | Buy |
|
|||||
|
2022
Q2 | $232K | Buy |
|
|||||
|
2022
Q1 | $247K | Buy |
|
|||||
|
2021
Q4 | $232K | Sell |
|
|||||
|
2021
Q3 | $530K | Buy |
|
|||||
|
2021
Q2 | $640K | Buy |
|
|||||
|
2021
Q1 | $587K | Sell |
|
|||||
|
2020
Q4 | $704K | Buy |
|
|||||
|
2020
Q3 | $557K | Sell |
|
|||||
|
2020
Q2 | $643K | Buy |
|
|||||
|
2020
Q1 | $277K | Buy |
|